BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15979268)

  • 1. Chemotherapy for colorectal cancer--an overview of current management for surgeons.
    Lawes D; Taylor I
    Eur J Surg Oncol; 2005 Nov; 31(9):932-41. PubMed ID: 15979268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview.
    Barber FD; Mavligit G; Kurzrock R
    Cancer Treat Rev; 2004 Aug; 30(5):425-36. PubMed ID: 15245775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
    Del Freo A; Fiorentini G; Sanguinetti F; Muttini MP; Pennucci C; Mambrini A; Pacetti P; Della Seta R; Lombardi M; Torri T; Cantore M
    In Vivo; 2006; 20(6A):743-6. PubMed ID: 17203759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: current management of metastatic colorectal cancer - the evolving impact of targeted drug therapies.
    Yau T; Chan P; Ching Chan Y; Wong BC; Liang R; Epstein RJ
    Aliment Pharmacol Ther; 2008 Jun; 27(11):997-1005. PubMed ID: 18363897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent progress in the treatment of colorectal cancer].
    Thuss-Patience PC; Reichardt P; Riess H; Kretzschmar A
    Med Klin (Munich); 2006 Feb; 101(2):114-9. PubMed ID: 16501908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced colorectal cancer.
    Abbruzzese JL; Levin B
    Hematol Oncol Clin North Am; 1989 Mar; 3(1):135-53. PubMed ID: 2465291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic therapy for metastatic colorectal cancer: current options, current evidence.
    Kelly H; Goldberg RM
    J Clin Oncol; 2005 Jul; 23(20):4553-60. PubMed ID: 16002847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic therapy for colorectal cancer: an overview.
    Mayer RJ
    Semin Oncol; 1991 Oct; 18(5 Suppl 7):62-6. PubMed ID: 1948131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in adjuvant and palliative chemotherapy of colorectal cancer: current status and perspectives].
    Scheithauer W
    Wien Klin Wochenschr; 1993; 105(20):568-79. PubMed ID: 7505075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H; Ozaki T; Shiina M
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy of stage III colon cancer.
    Benson AB
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S74-7. PubMed ID: 16399437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival.
    Hotta T; Takifuji K; Arii K; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Oku Y; Yamaue H
    Anticancer Res; 2006; 26(2B):1425-32. PubMed ID: 16619554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
    Ducreux M; Ychou M; Laplanche A; Gamelin E; Lasser P; Husseini F; Quenet F; Viret F; Jacob JH; Boige V; Elias D; Delperro JR; Luboinski M;
    J Clin Oncol; 2005 Aug; 23(22):4881-7. PubMed ID: 16009952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant therapy of colon cancer: current status and future directions.
    Chung KY; Saltz LB
    Cancer J; 2007; 13(3):192-7. PubMed ID: 17620769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in systemic chemotherapy of metastatic colorectal cancer.
    Seitz JE; Rougier P; Giovannini M
    Ann Ital Chir; 1996; 67(6):805-12. PubMed ID: 9125692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palliative chemotherapy for recurrent and metastatic esophageal cancer.
    Grünberger B; Raderer M; Schmidinger M; Hejna M
    Anticancer Res; 2007; 27(4C):2705-14. PubMed ID: 17695436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective study of bifractionated CPT-11 with LF5FU infusion (FOLFIRI-3) in colorectal cancer patients pretreated with oxaliplatin and CPT-11 containing chemotherapies.
    Viel E; Demarchi MF; Chaigneau L; Nguyen T; Legat C; Stein U; Thiery-Vuillemin A; Limat S; Pivot X; Borg C
    Am J Clin Oncol; 2008 Feb; 31(1):89-94. PubMed ID: 18376234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab: new drug. Metastatic colorectal cancer: good in theory, not in practice.
    Prescrire Int; 2006 Jun; 15(83):94-7. PubMed ID: 16764097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the treatment of metastatic colorectal cancer.
    Goldberg RM
    Oncologist; 2005; 10 Suppl 3():40-8. PubMed ID: 16368870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.